Cns Pharmaceuticals Inc Share Price

NASDAQ: CNSP

Small Cap

$8.88

-0.26

(-2.84%)

as on September 18, 2025 at 1:29 am IST

$₹

Cns Pharmaceuticals Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's Low
Day's High
$8.52
Day's Price Range
$8.94
$8.88
4.05%
Downside
0.68%
Upside
52 Week's Low
52 Week's High
$4.93
52-Week Price Range
$221.94
$8.88
44.48%
Downside
2399.32%
Upside

Cns Pharmaceuticals Inc share price movements today

Previous Close: $9.14
Open: $8.83
Volume: 145.6K
Day's Low - High: $8.52 - $8.94
52 Week Low - High: $4.93 - $221.94

Cns Pharmaceuticals Inc Historical Returns

1 Month Return: + 41.03 %
3 Month Return: -12.54 %
1 Year Return: -90.91 %
3 Year Return: -100 %
5 Year Return: -100 %

Cns Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Cns Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.0M

EPS (TTM)

-31.41

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

Industry PE ratio

0

P/B Ratio

0.0041

PEG Ratio

0

EBITDA

-15.6M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-350.08%

Cns Pharmaceuticals Inc Stock Valuation

Track how Cns Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.

Cns Pharmaceuticals Inc in the last 5 years

Overview
Trends

Lowest (0.00x)

September 18, 2025

Industry (0.00x)

September 18, 2025

Today (0.00x)

September 18, 2025

Highest (-0.01x)

September 30, 2024

LowHigh

Today’s Price to Earnings Ratio: 0.00x

Cns Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cns Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Cns Pharmaceuticals Inc	SELL	$5.0M	-100%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	241.54%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$99.3B	45.88%	27.56	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$60.9B	5.45%	14.49	31.37%

Stock Returns calculator for Cns Pharmaceuticals Inc Stock including INR - Dollar returns

The Cns Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

1Y
3Y
5Y

Cns Pharmaceuticals Inc investment value today

Current value as on today

₹14,203

Returns

₹85,797

(-85.8%)

Returns from Cns Pharmaceuticals Inc Stock

₹90,750 (-90.75%)

Dollar Returns*

₹4,953 (+4.95%)

Analyst Recommendation on Cns Pharmaceuticals Inc Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Cns Pharmaceuticals Inc. Average target price of $52

Cns Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Cns Pharmaceuticals Inc.

What analysts predicted

82.92%UPSIDE

Target Price

$52

Current Price

$8.88

Analyzed by

6 Analysts

Target

$52.00

Cns Pharmaceuticals Inc target price $52, a slight upside of 82.92% compared to current price of $8.88. According to 6 analysts rating.

Cns Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for Cns Pharmaceuticals Inc Stock has decreased by -23% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:-23% versus previous 30 day period

Cns Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	0	-	-	0	0	-
Gross Profit	0	0	0	-	0	0	0	0	0	0
Operating Income	-4	-4	-4	-5	-3	-2	-5	-3	-4	-2
EBITDA	-4	-4	-4	-	-3	-2	-5	-3	-4	-2
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-4	-4	-4	-5	-3	-2	-5	-3	-4	-2
Income Tax Expense	0	0	0	-	0	0	-	-	-	-
Net Income	-4	-4	-4	-5	-3	-2	-5	-3	-4	-2
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-55717.51%	0.00%	0.00%	-101158.15%	-136984.71%	0.00%

Cns Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	-
Gross Profit	-	0	0	0	0	0	0
Operating Income	0	-3	-9	-14	-15	-18	-14
EBITDA	-6	-3	-9	-14	-15	-18	-14
Interest Expense	0	0	0	0	0	0	0
Depreciation	-	0	0	0	0	0	0
Income Before Tax	-7	-3	-9	-14	-15	-18	-14
Income Tax Expense	0	0	0	0	0	0	-
Net Income	-7	-3	-9	-14	-15	-18	-14
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Cns Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-4	-4	-5	-3	-2	-5	-3	-4	-2
Operating Cash Flow	-3	-3	-2	-3	-1	-6	-5	-3	-5
Investing Cash Flow	-	0	-	0	-	-	0	0	-
Financing Cash Flow	2	0	2	3	2	12	4	9	4
Change in Cash	0	-3	0	0	0	5	0	6	0

Cns Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-7	-3	-9	-14	-15	-18	-14
Operating Cash Flow	0	-3	-7	-13	-10	-14	-17
Investing Cash Flow	0	0	0	0	0	0	0
Financing Cash Flow	1	10	14	4	15	4	23
Change in Cash	0	6	6	-9	5	-9	5

Global Institutional Holdings in Cns Pharmaceuticals Inc

Funds	Holdings
UBS Group AG	0.38%
Ground Swell Capital, LLC	0.18%
Tower Research Capital LLC	0.08%
BARRETT & COMPANY, INC.	0%
Mccormack Advisors International	0%

See all

Insights on Cns Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, CNSP stock has moved up by 16.1%
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 159.3%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 211.5%

About Cns Pharmaceuticals Inc

cns pharmaceuticals, inc., a biopharmaceutical company, engages in the development of anti-cancer drug candidates for primary and metastatic cancers of the brain and central nervous system. the company's lead drug candidate is berubicin, which completed phase i clinical trial that is used for the treatment of glioblastoma multiforme. it has license agreements with houston pharmaceuticals, inc. and the university of texas m.d. anderson cancer center; and a development agreement with wpd pharmaceuticals inc. cns pharmaceuticals, inc. was founded in 2017 and is based in houston, texas.

Organisation	Cns Pharmaceuticals Inc
Headquarters	2100 West Loop South, Houston, TX, United States, 77027
Industry	Health Technology
CEO	Mr. John Michael Climaco Esq., J.D.
E-voting on shares	Click here to vote

Key Management of Cns Pharmaceuticals Inc

Name	Title
Mr. John Michael Climaco Esq., J.D.	CEO, President & Director
Mr. Christopher S. Downs CPA, CTP, FP&A	Chief Financial Officer
Dr. Sandra L. Silberman M.D., Ph.D.	Chief Medical Officer
Dr. Donald H. Picker Ph.D.	Chief Science Officer

FAQs

What is Cns Pharmaceuticals Inc share price today?

Cns Pharmaceuticals Inc share price today is $8.88 as on September 18, 2025 at 1:29 am IST at the close of the market. Cns Pharmaceuticals Inc share today touched a day high of $8.94 and a low of $8.52.

What is the 52 week high and 52 week low for Cns Pharmaceuticals Inc share?

Cns Pharmaceuticals Inc share touched a 52 week high of $221.94 on October 23, 2024 and a 52 week low of $4.93 on August 15, 2025. Cns Pharmaceuticals Inc stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $8.88,which is 96.00% down from its 52 week high and 80.12% up from its 52 week low.

What is Cns Pharmaceuticals Inc's market capitalisation today?

Cns Pharmaceuticals Inc market capitalisation is $0.00T as on September 18, 2025 at 1:29 am IST.

How to invest in Cns Pharmaceuticals Inc Stock (CNSP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cns Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cns Pharmaceuticals Inc Shares that will get you 0.1689 shares as per Cns Pharmaceuticals Inc share price of $8.88 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Cns Pharmaceuticals Inc Stock (CNSP) from India?

Indian investors can start investing in Cns Pharmaceuticals Inc (CNSP) shares with as little as ₹88.114 or $1 (as of September 18, 2025 at 6:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Cns Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 6:42 pm IST). Based on Cns Pharmaceuticals Inc share’s latest price of $8.88 as on September 18, 2025 at 1:29 am IST, you will get 1.1261 shares of Cns Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Cns Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Cns Pharmaceuticals Inc stock has given -100% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?